Latest News
- March 4, 2022
Vineti Appoints Ann Klein as Chief Executive Officer
Ms. Klein brings more than 25 years of healthcare technology product strategy, management, sales and marketing experience as Vineti extends…
- January 26, 2022
Vineti achieves SOC2 Type II compliance
Vineti announced the successful completion of its Service Organization Control (SOC®) 2 Type II audit. The independent audit, conducted by…
- January 10, 2022
Vineti introduces new PTM® Integration Suite: purpose-built connectivity and interoperability for cell and gene therapies
Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a…
- December 8, 2021
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
The non-exclusive collaboration will bring together industry leaders in workflow and logistics solutions — Be The Match BioTherapies’ cellular therapy supply chain management services and…
- October 19, 2021
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management® (PTM) platform. This will enable both parties…
- October 12, 2021
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
Together, Körber and Vineti will streamline process development, operations, and manufacturing to deliver advanced therapies to patients in need around…
- August 13, 2021
Lykan and Vineti Form Cell Therapy Agreement
Partnership will streamline process development and manufacturing to deliver therapies to patients in need.
- August 12, 2021
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will…
- August 10, 2021
Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients…
- August 3, 2021
Uncharted Podcast #94, Democratizing healthcare and the importance of continuous learning with Amy DuRoss, CEO and Co-founder of Vineti by Uncharted Podcast
Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain…
- July 15, 2021
PharmaVoice 100 Entrepreneurs
These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights.
We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.